Patents by Inventor Ralph Ellison

Ralph Ellison has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for the treatment of Primary and metastatic neoplastic diseases using arsenic compounds
    Publication number: 20050191367
    Abstract: The invention relates to the use of arsenic compounds to treat a variety of neoplastic diseases. The present invention encompasses the administration to a mammal of arsenic in the form of a salt, complex, organic compound or ionic solution to treat tumors of epithelial tissue, connective tissue, central nervous system, lymphoid tissue, hematopoietic cells and tumors associated with oncogenic viruses. This invention also encompasses the treatment of hematopoietic disorders in mammals by the administration of one or more arsenic compounds to said mammal. Further, the arsenic compounds may be used to treat metastatic neoplastic diseases.
    Type: Application
    Filed: August 14, 2003
    Publication date: September 1, 2005
    Inventors: Ralph Ellison, Fred Mermelstein
  • Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds
    Publication number: 20050100611
    Abstract: The invention relates to the use of arsenic compounds to treat a variety of neoplastic diseases. The present invention encompasses the administration to a mammal of arsenic in the form of a salt, complex, organic compound or ionic solution to treat tumors of epithelial tissue, connective tissue, central nervous system, lymphoid tissue, hematopoietic cells and tumors associated with oncogenic viruses. This invention also encompasses the treatment of hematopoietic disorders in mammals by the administration of one or more arsenic compounds to said mammal. Further, the arsenic compounds may be used to treat metastatic neoplastic diseases.
    Type: Application
    Filed: August 14, 2003
    Publication date: May 12, 2005
    Inventors: Ralph Ellison, Fred Mermelstein
  • Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
    Publication number: 20030211171
    Abstract: The invention relates to the use of arsenic compounds to treat a variety of leukemia, lymphoma and solid tumors. Further, the arsenic compounds may be used in combination with other therapeutic agents, such as a retinoid. The invention also provides a process for producing arsenic trioxide formulations.
    Type: Application
    Filed: April 30, 2003
    Publication date: November 13, 2003
    Applicant: Memorial Sloan-Kettering Cancer Center
    Inventors: Raymond P. Warrell, Pier Paolo Pandolfi, Janice L. Gabrilove, Ralph Ellison, Steven Soignet
  • Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
    Publication number: 20030099719
    Abstract: The invention relates to the use of arsenic compounds to treat a variety of leukemia, lymphoma and solid tumors. Further, the arsenic compounds may be used in combination with other therapeutic agents, such as a retinoid. The invention also provides a process for producing arsenic trioxide formulations.
    Type: Application
    Filed: September 30, 2002
    Publication date: May 29, 2003
    Applicant: Memorial Sloan-Kettering Cancer Center Cell Therapeutics, Inc.
    Inventors: Raymond P. Warrell, Pier P. Pandolfi, Janice L. Gabrilove, Ralph Ellison, Steven Soignet